-
Tofacitinib Rewires RA Macrophage Immunometabolism
2026-08-25
Tofacitinib (CP-690550, Tasocitinib) offers translational researchers more than pathway inhibition: in GM-CSF-reprogrammed rheumatoid arthritis macrophages, it links JAK/STAT perturbation to inflammatory resolution and mitochondrial repair. This thought-leadership guide translates those findings into assay design, competitive strategy, and evidence-led immune modulation research.
-
GKT137831: From ROS Source to Membrane Fate
2026-08-25
GKT137831 is a dual NADPH oxidase Nox1/Nox4 inhibitor for dissecting how ROS generation influences vascular remodeling, fibrosis, and membrane injury. This article connects Nox-centered assay design with new ferroptosis biology, showing how to distinguish upstream oxidant production from terminal plasma-membrane failure.
-
Chloroquine for Autophagy and Cementoblast Research
2026-08-24
Chloroquine offers a practical way to test whether lysosomal autophagy is causally linked to cementoblast mineralization under mechanical compression. This workflow combines dose-controlled perturbation, mineralization readouts, autophagic-flux checks, and periostin/β-catenin validation while separating mechanistic evidence from broader oncology, antiviral, malaria, and rheumatoid arthritis applications.
-
Isochlorogenic acid A: Reliable Cell Assays
2026-08-24
A scenario-based guide to using Isochlorogenic acid A (3,5-Dicaffeoylquinic acid), SKU N1755, in cell viability, proliferation, and cytotoxicity workflows. It connects formulation, controls, protocol optimization, literature evidence, and reagent-selection decisions for reproducible natural product research.
-
Polyethylenimine Linear: PEI MW 40,000 Workflows
2026-08-23
Build reproducible DNA delivery workflows with Polyethylenimine Linear, PEI MW 40,000, from HEK-293 transfection screens to recombinant protein production. Practical optimization strategies distinguish PEI complex formation from calcium-phosphate precipitation, helping laboratories improve expression while protecting cell viability.
-
Tetramethylrhodamine ethyl ester perchlorate Workflow
2026-08-22
Build sensitive live-cell mitochondrial membrane potential assays with a practical TMRE workflow for microscopy, flow cytometry, and toxin-response studies. The approach distinguishes mitochondrial depolarization from broader oxidative stress and translates recent caspase-3/NDUFS1 findings into actionable experimental controls.
-
TAK-242 (Resatorvid) for TLR4 Workflows
2026-08-22
TAK-242 (Resatorvid) enables receptor-proximal interrogation of LPS-driven inflammation, from macrophage cytokine assays to aged-rat neuroinflammation models. This practical guide connects dose selection, orthogonal readouts, controls, and troubleshooting to help distinguish TLR4 pathway effects from toxicity or nonspecific inflammatory suppression.
-
Smo Signaling and Olfaction in Honeybees
2026-08-21
Guo et al. characterize Smoothened (Smo) in Apis mellifera and provide pharmacological and physiological evidence that Hedgehog signaling influences olfactory receptor expression and odor-guided behavior. The study expands Smo research beyond developmental biology by connecting this conserved pathway with antennal sensory function, while also defining important limits for transferring agonist doses across experimental systems.
-
DiI (DiIC18(3)) Membrane Labeling Guide
2026-08-20
DiI (DiIC18(3)), SKU B8804, provides orange-red plasma membrane labeling for live or fixed cells and tissues in membrane-focused workflows such as neuronal tracing, migration, and cell fusion studies. Its lipophilic chemistry makes it unsuitable for aqueous-only staining, intracellular organelle labeling, and detergent-heavy protocols unless membrane localization is specifically validated.
-
Substance P: Mechanism, Evidence, and Workflow
2026-08-20
Substance P is a tachykinin neuropeptide that activates neurokinin-1 receptors and supports mechanistic studies of pain transmission, inflammation, and neuroimmune signaling. Reliable interpretation requires separating receptor biology, product-specific handling, and spectral methods that were not validated specifically for this peptide.
-
Digestive Transformations of Ashwagandha Extracts
2026-08-19
The reference study combines simulated gastrointestinal digestion, LC–MS/MS profiling, untargeted metabolomics, and molecular networking to track how Withania somnifera leaf and root constituents change before absorption. Withaferin A and withanoside IV were transformation-prone, whereas withanolide A remained comparatively stable, demonstrating why botanical bioavailability studies should evaluate matrix- and tissue-specific digestive behavior.
-
Afatinib in Patient-Derived Cancer Assembloids
2026-08-19
Afatinib, also known as BIBW 2992, offers a mechanistically defined way to interrogate EGFR, HER2, and HER4 dependence in patient-derived gastric cancer assembloids. By pairing irreversible ErbB inhibition with tumor–stroma modeling, translational researchers can distinguish tumor-intrinsic sensitivity from microenvironment-mediated resistance and build more clinically informative targeted therapy research workflows.
-
HyperFluor™ 594 Antibody: From Causality to Imaging
2026-08-18
Learn how the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody converts causal atherosclerosis findings into rigorous spatial, cellular, and quantitative assays. This guide emphasizes assay logic, controls, multiplex design, and interpretation across immunofluorescence, histology, flow cytometry, and ELISA.
-
N-MYC–eIF4G1 Signaling in inv(16) AML
2026-08-18
The reference study identifies an N-MYC–eIF4G1 survival axis that maintains acute myeloid leukemia with inv(16), linking a previously uncharacterized MYCN enhancer to leukemic cell fitness. Its combination of transcriptomic, chromatin, genetic, primary-cell, and patient-derived xenograft analyses provides a framework for studying transcriptional dependencies in genetically defined AML.
-
N-MYC/eIF4G1 Survival Axis in inv(16) AML
2026-08-17
Peramangalam et al. identify a previously unrecognized MYCN enhancer and establish an N-MYC/eIF4G1 pathway that supports survival in inv(16) acute myeloid leukemia. The study connects CBFβ-SMMHC-dependent transcriptional dysregulation to translational control and provides a mechanistic framework for targeted acute myeloid leukemia research.